Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Korean Journal of Veterinary Research ; : e15-2023.
Article in English | WPRIM | ID: wpr-1002450

ABSTRACT

The hepatitis A virus (HAV) induces severe acute liver injury and is adapted to human and monkey cell lines but not other cells. In this study, the HAV was inoculated into porcine kidney (PK-15) cells to determine its infectivity in porcine cells. The growth pattern of the HAV in PK-15 cells was compared with its growth pattern in fetal rhesus kidney (FRhK-4) cells. The growth of HAV was less efficient in PK-15 cells. In conclusion, HAV replication was verified in PK-15 cells for the first time. Further investigations will be needed to identify the HAV-restrictive mechanisms in PK-15 cells.

2.
Journal of the Korean Society of Hypertension ; : 48-56, 2011.
Article in Korean | WPRIM | ID: wpr-119731

ABSTRACT

BACKGROUND: Hypertensive myocardial fibrosis promotes abnormalities of cardiac function that may adversely affect the clinical outcome of hypertensive patients. Imatinib mesylate blocks receptor tyrosine kinase and is clinically used to treat leukemia. Platelet-derived growth factor (PDGF) is a downstream target of receptor tyrosine kinases. Cardiac fibroblasts can be activated by PDGF. Thus we evaluated whether imatinib attenuate myocardial fibrosis and prevents diastolic dysfunction in spontaneously hypertensive rats (SHR). METHODS: 8 weeks old male SHRs were subjected to treatment with 8 weeks of low dose imatinib (SHR-10; 10 mg/kg), high dose imatinib (SHR-30; 30 mg/kg) or saline (SHR-C; n = 6 in each group). At the age of 16 weeks, all rats underwent hemodynamic studies and Doppler echocardiography, and were sacrificed. Their hearts were extracted for histopathological, immunoblotting and quantitative reverse transcriptase-polymerase chain reaction analyses. RESULTS: While imatinib did not affect blood pressure (BP), it markedly reduced perivascular and interstitial fibrosis in the hearts of SHR. Echocardigram showed that high-dose imatinib significantly reduced left ventricular (LV) wall thickness (septal/posterior wall; SHR-C vs. SHR-30: 18 +/- 2/19 +/- 2 mm vs. 15 +/- 1/14 +/- 1 mm; p < 0.05) and improved the parameters of LV diastolic function such as E/A ratio (SHR-C vs. SHR-30: 1.60 +/- 0.10 vs. 1.86 +/- 0.20; p < 0.05). Imatinib also significantly reduced mRNA expression of collagen III and PDGF beta-receptor tyrosine phosphorylation in the hearts of SHR. CONCLUSIONS: These results suggest that imatinib, especially high dose, could attenuate myocardial fibrosis and prevent LV diastolic dysfunction in hypertensive rat model by decreased activity of PDGF. Imatinib may provide a potential therapeutic approach for hypertensive heart disease.


Subject(s)
Animals , Humans , Male , Rats , Benzamides , Blood Pressure , Collagen , Diastole , Echocardiography , Echocardiography, Doppler , Fibroblasts , Fibrosis , Heart , Heart Diseases , Hemodynamics , Immunoblotting , Leukemia , Mesylates , Phosphorylation , Phosphotransferases , Piperazines , Platelet-Derived Growth Factor , Protein-Tyrosine Kinases , Pyrimidines , Rats, Inbred SHR , RNA, Messenger , Tyrosine , Imatinib Mesylate
3.
Journal of Korean Epilepsy Society ; : 143-147, 2005.
Article in Korean | WPRIM | ID: wpr-113451

ABSTRACT

PURPOSE: Hippocampal sclerosis is known to strongly correlate with medical intractability of temporal lobe epilepsy. However, the informations about this have been biased due to improper selection of the sampling obtained from severe cases of tertiary epilepsy center and surgical epilepsy field. We tried to investigate the influence of hippocampal sclerosis on the pharmacoresistance in temporal lobe epilepsy by group comparison study. METHODS: The fifty patients with complex partial seizures of temporal lobe origin, and temporal spike on EEG and/or hippocampal sclerosis on brain MRI were selected. Follow-up period of them were more than 2 years. The patients who had a seizure or seizures during the last 1-year period and had already been in adequate doses of two or more antiepileptic drugs were considered to be poorly controlled epileptics. RESULTS: Five of 17 patients without hippocampal sclerosis (29. 4%) and 24 of 33 patients with hippocampal sclerosis (72.7%) were poorly controlled by medication and the difference was significant (p=0.003, chi-square). Other factors, including sex, age of onset, febrile convulsion, secondary generalization, familial history of epilepsy, duration of disease, and delay of initial therapy had no significant effects on medical response (p>0.05). The only independent predictor of intractable epilepsy after multiple logistic regression analysis was also hippocampal sclerosis (p=0.005). CONCLUSION: Medical response in temporal lobe epilepsy was significantly associated with hippocampal sclerosis. Hippocampal sclerosis on brain MRI itself may be a crucial factor determining pharmacoresistance of temporal lobe epilepsy.


Subject(s)
Humans , Age of Onset , Anticonvulsants , Bias , Brain , Drug Resistance , Electroencephalography , Epilepsy , Epilepsy, Complex Partial , Epilepsy, Temporal Lobe , Follow-Up Studies , Generalization, Psychological , Hippocampus , Logistic Models , Magnetic Resonance Imaging , Sclerosis , Seizures , Seizures, Febrile , Temporal Lobe
4.
Journal of the Korean Neurological Association ; : 67-69, 2002.
Article in Korean | WPRIM | ID: wpr-64907

ABSTRACT

Acute cerebellitis is an uncommon neurological complication that may occur following childhood viral infections, and is rarely reported in adults. Imaging studies show no abnormalities in the majority of cases. We experienced three cases of acute cerebellitis, which showed no abnormal findings on MRI, but revealed diffusely increased cerebellar per-fusions on brain perfusion SPECT, which normalized 5~6 months later. Therefore, brain perfusion SPECT is consid-ered to be useful in identifying acute cerebellitis and in monitoring its clinical course.


Subject(s)
Adult , Humans , Brain , Magnetic Resonance Imaging , Perfusion , Technetium Tc 99m Exametazime , Tomography, Emission-Computed, Single-Photon
5.
Journal of the Korean Surgical Society ; : 419-424, 1998.
Article in Korean | WPRIM | ID: wpr-70614

ABSTRACT

Desmoid tumor is a infrequent, but particular type of fibromatosis (dysplastic lesion of connective tissue), usually originating in the fascial sheath or musculoaponeurotic tissue of the body. It is characterized by its propensity for slow, incessant growth and by its nonmetastastic but locally aggressive behavior. While rarely associated with this tumor, morbidity and mortality occur when there is encroachment on vital structures. Because of the scarcity of data, the relatively small number of patients and the pathological resembrance to low-grade fibrosarcoma, desmoid tumor may be easily misdiagnosed and wrong conclusions regarding its biological behavior may be drawn. Also, the optimal treatment for this tumor remains controversial. At present, the most successful method of control of desmoid tumor is complete excision with a clear margin of normal tissue surrounding the tumor. To better delineate the natural history and the result of managing patients with this disease, we have reviewed all patients with desmoid tumor treated at our hostital from 1985 to 1996, and the following results were obtained : The male-to-female ratio was 1 : 2.7, and a childbearing-aged female preponderance was present like most reports. Seven of 22 patients(32 %) developed local recurrence. The recurrence of desmoid tumor was not related to patient's sex/age, location/size of the tumor, and previous operative history. Even though desmoid tumor is not pathologically malignant, it should be regarded as clinical malignancy and be treated by wide excision with pathologically-proven safe resectional margin.


Subject(s)
Female , Humans , Fibroma , Fibromatosis, Aggressive , Fibrosarcoma , Mortality , Natural History , Recurrence
SELECTION OF CITATIONS
SEARCH DETAIL